Background Ventilator‐associated pneumonia (VAP) is associated with increased mortality,
prolonged length of hospital stay and increased healthcare costs in critically ill patients …

Ventilator-associated pneumonia (VAP) is one of the most frequent nosocomial infections
among ventilated patients in ICUs, associated with an increase in days of ICU stay …

Introduction Ventilator-associated pneumonia is a common nosocomial infection that occurs
in critically ill patients who are on intubation and mechanical ventilation. Nurses' lack of …

OBJECTIVES: To explore critical care nurses' knowledge of, adherence to and barriers
towards evidence-based guidelines for prevention of ventilator-associated pneumonia …

Background Implementation of evidence-based guidelines (EBGs) related to VAP is an
effective measure for the prevention of ventilator-associated pneumonia (VAP). While low …

Abstract Objective To explore Australian intensive care nurses' knowledge of ventilator-
associated pneumonia and self-reported adherence to evidence-based guidelines for the …

Aims and objectives To evaluate the effectiveness of chlorhexidine for the prevention of
ventilator‐associated pneumonia and explore the preferred concentration of chlorhexidine …

Background Although evidence-based practices are known to improve the quality of care,
making it cost-efficient and improving clinical results, barriers to transferring research into …

Background: Ventilator-Associated Pneumonia (VAP) is a recognized nosocomial infection
and a leading cause of high morbidity and mortality. Intensive Care Unit (ICU) nurses are in …

Objective To determine how the patient to nurse ratio affects risk for ventilator-associated
pneumonia. Methods Data from an earlier study in 27 intensive care units in 9 European …